Literature DB >> 27643448

Diurnal Plasma Cortisol Measurements Utility in Differentiating Various Etiologies of Endogenous Cushing Syndrome.

A Tirosh1, M B Lodish1, G Z Papadakis2, C Lyssikatos1, E Belyavskaya1, C A Stratakis1.   

Abstract

Cortisol diurnal variation may be abnormal among patients with endogenous Cushing syndrome (CS). The study objective was to compare the plasma cortisol AM/PM ratios between different etiologies of CS. This is a retrospective cohort study, conducted at a clinical research center. Adult patients with CS that underwent adrenalectomy or trans-sphenoidal surgery (n=105) were divided to those with a pathologically confirmed diagnosis of Cushing disease (n=21) and those with primary adrenal CS, including unilateral adrenal adenoma (n=28), adrenocortical hyperplasia (n=45), and primary pigmented nodular adrenocortical disease (PPNAD, n=11). Diurnal plasma cortisol measurements were obtained at 11:30 PM and midnight and at 7:30 and 8:00 AM. The ratios between the mean morning levels and mean late-night levels were calculated. Mean plasma cortisol AM/PM ratio was lower among CD patients compared to those with primary adrenal CS (1.4±0.6 vs. 2.3±1.5, p<0.001, respectively). An AM/PM cortisol ratio≥2.0 among patients with unsuppressed ACTH (>15 pg/ml) excludes CD with a 85.0% specificity and a negative predictive value (NPV) of 90.9%. Among patients with primary adrenal CS, an AM/PM cortisol≥1.2 had specificity and NPV of 100% for ruling out a diagnosis of PPNAD. Plasma cortisol AM/PM ratios are lower among patients with CD compared with primary adrenal CS, and may aid in the differential diagnosis of endogenous hypercortisolemia. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27643448      PMCID: PMC6341983          DOI: 10.1055/s-0042-115644

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  21 in total

1.  The circadian rhythm of glucocorticoids is regulated by a gating mechanism residing in the adrenal cortical clock.

Authors:  Henrik Oster; Sebastian Damerow; Silke Kiessling; Vladimira Jakubcakova; Diya Abraham; Jiong Tian; Matthias W Hoffmann; Gregor Eichele
Journal:  Cell Metab       Date:  2006-08       Impact factor: 27.287

2.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

3.  Familial micronodular adrenocortical disease, Cushing syndrome, and mutations of the gene encoding phosphodiesterase 11A4 (PDE11A).

Authors:  J Aidan Carney; Rolf C Gaillard; Jérôme Bertherat; Constantine A Stratakis
Journal:  Am J Surg Pathol       Date:  2010-04       Impact factor: 6.394

4.  Incidence and late prognosis of cushing's syndrome: a population-based study.

Authors:  J Lindholm; S Juul; J O Jørgensen; J Astrup; P Bjerre; U Feldt-Rasmussen; C Hagen; J Jørgensen; M Kosteljanetz; L Kristensen; P Laurberg; K Schmidt; J Weeke
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

5.  Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group.

Authors:  R Görges; G Knappe; H Gerl; M Ventz; F Stahl
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

Review 6.  Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency.

Authors:  Hershel Raff
Journal:  J Clin Endocrinol Metab       Date:  2009-07-14       Impact factor: 5.958

Review 7.  Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome).

Authors:  Constantine A Stratakis
Journal:  Endocr Dev       Date:  2008

Review 8.  Approach to the patient with possible Cushing's syndrome.

Authors:  Marco Boscaro; Giorgio Arnaldi
Journal:  J Clin Endocrinol Metab       Date:  2009-09       Impact factor: 5.958

9.  Specificity of first-line tests for the diagnosis of Cushing's syndrome: assessment in a large series.

Authors:  Francesca Pecori Giraldi; Alberto G Ambrogio; Martina De Martin; Letizia M Fatti; Massimo Scacchi; Francesco Cavagnini
Journal:  J Clin Endocrinol Metab       Date:  2007-08-14       Impact factor: 5.958

10.  Association of diurnal patterns in salivary cortisol with all-cause and cardiovascular mortality: findings from the Whitehall II study.

Authors:  Meena Kumari; Martin Shipley; Mai Stafford; Mika Kivimaki
Journal:  J Clin Endocrinol Metab       Date:  2011-02-23       Impact factor: 5.958

View more
  2 in total

1.  Computerized Analysis of Brain MRI Parameter Dynamics in Young Patients With Cushing Syndrome-A Case-Control Study.

Authors:  Amit Tirosh; Harish RaviPrakash; Georgios Z Papadakis; Christina Tatsi; Elena Belyavskaya; Lyssikatos Charalampos; Maya B Lodish; Ulas Bagci; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

2.  ARMC5 variants in PRKAR1A-mutated patients modify cortisol levels and Cushing's syndrome.

Authors:  Andrea Gutierrez Maria; Christina Tatsi; Annabel Berthon; Ludivine Drougat; Nikolaos Settas; Fady Hannah-Shmouni; Jerome Bertherat; Fabio R Faucz; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2020-09       Impact factor: 5.900

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.